Pricing

Heron Therapeutics Inc (HRTX)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Barry D. Quart
Employees: 300
Web site: herontx.com
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
8582514400
    Formally known as:
  • Advanced Polymer Systems Inc
  • AP Pharma Inc
  • AP PHARMA INC
  • AP Pharma Inc
  • HERON THERAPEUTICS INC NEW COM STK
Stock Split History
Date Ratio
2007-05-25 1:4
2014-01-13 1:20
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Heron Therapeutics, Inc. engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available